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1. Introduction 
1.1 Types, utilities and limitations of PCR 
Nowadays, advances and applications of research in biochemistry and genetic play an 
important role in the field of health sciences. This has become necessary a molecular 
approach of the disease for a better interpretation of processes and as horizon in the 
development of new diagnostic and therapeutic strategies. Therefore, techniques in 
molecular biology have modified diagnosis, prevention and control of diseases in living 
beings. Molecular technology has become a crucial tool for identifying new genes with 
importance in medicine, agriculture, animal production and health, environment and the 
industry related to these areas. Among the applications of molecular techniques is 
important to highlight the use of the Polymerase Chain Reaction (PCR) in the identification 
and characterization of viral, bacterial, parasitic and fungal agents. This technique was 
developed by Kary Mullis in the mid 80's [1, 2, 3, 4] and since then it has been considered as 
an essential tool in molecular biology which allows amplification of nucleic acid sequences 
(DNA and RNA) through repetitive cycles in vitro. The mechanisms involved in this 
methodology are similar to those occurring in vivo during DNA replication. Each cycle had 
three temperature patterns carried out by a thermocycler. The first pattern of temperature is 
94 °C (denaturation), the second one is 45 - 55 °C (alignment of the specific primers) and the 
third one is 72 °C (final extension). The amplification of specific nucleic acid sequences, even 
in the presence of millions of other DNA molecules, is achieved by thermostable DNA 
polymerase enzyme (as the name of this technique suggests: “polymerase chain reaction”) 
and specific primers. Primers are short sequences of DNA or RNA (oligonucleotides) that 
initiate DNA synthesis. These are complementary to the template strand of DNA. The total 
duration of PCR reaction is around two hours; this depends on the specific conditions of the 
reaction. Therefore, the DNA polymerase enzyme is capable of producing a complementary 
strand of a template DNA. In summary, the requirements of PCR are as follows: i. Template 
DNA; ii. Four deoxyribonucleotides (dNTPs: dATP, dTTP, dGTP and dCTP) which are the 
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base material to make the new strand from template DNA; iii. Two primers or 
oligonucleotides; iv. Mg2+ which joins to nucleotides to be recognized by the polymerase 
enzyme; and, v. Thermostable DNA polymerase enzyme. The synthesized product in each 
cycle can serve as a template in the next issue of copies of DNA, creating a chain reaction 
that can amplify a specific fragment of DNA. Requirements and purpose of PCR are showed 
in figure 1. 
 
Fig. 1. Requirements and purpose of amplification cycles (denaturation, annealing and 
extension) in a polymerase chain reaction (PCR). 
PCR is a relatively simple technique that can detect a nucleic acid fragment and amplify this 
sequence. In addition, this technique has other advantages that are described below. This 
technique offers sensitivity because from small amounts of genetic material can be detected 
target sequences in a sample. Also this offers specificity due to a specific sequence of DNA is 
amplified through strict conditions. It is considered a fast technique compared with other 
methods to detect microorganisms such as bacteria, fungus or virus, which require isolation 
and culture using culture media or cell lines. Finally we can mention that offers versatility 
due to the genetic sequences from various microorganisms can be identified with the same 
reaction conditions for diagnosis of different pathologies [4, 5, 6, 7]. 
In recent years, modifications or variants have been developed from the basic PCR method 
to improve performance and specificity, and to achieve the amplification of other molecules 
of interest in research as RNA. Some of these variants are: i. Multiplex PCR which 
simultaneously amplified several DNA sequences (usually exonic sequences); ii. Nested 
PCR increases the specificity of the amplified product for a second PCR with new primers 
that hybridize within the amplified fragment in the first PCR; iii. Semiquantitative PCR 
which allows an approximation to the relative amount of nucleic acids present in a sample; 
iv. RT-PCR which generates amplification of RNA by synthesis of cDNA (DNA 
complementary to RNA) that is then amplified by PCR; and, v. Real time PCR which 
performs absolute or relative quantification of nucleic acid copies obtained by PCR. The 
principles of each of the above techniques are described following. 
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1.2 Multiplex PCR 
Multiplex PCR is an adaptation of PCR which allows simultaneous amplification of many 
sequences. This technique is used for diagnosis of different diseases in the same sample [8, 
9]. Multiplex PCR can detect different pathogens in a single sample [10, 11, 12]. Also it can 
be used to identify exonic and intronic sequences in specific genes [13] (figure 2) and 
determination of gene dosage (figure 2, 3 and 4). This is achieved when in a single tube  
 
Fig. 2. Results of a multiplex PCR in a patient with Duchenne Muscular Dystrophy. 
Dystrophy gene has different mutations in exons; this is the cause of disease. In lane 7 is 
shown the absence of a band corresponding to exon 48 (506 bp) of the dystrophy gene 
(Hernández-Rodríguez et al., 2000; Hernández-Rodríguez & Restrepo, 2002). 
 
Fig. 3. A: Requirements for multiplex PCR. This molecular method is useful for identification 
of deletion and duplication mutations. B: Electrophoretogram showing duplication (area under 
the curve amplified compared to normal) and deletion (area under the curve reduced compared 
to normal) obtained by analysis of gene dosage. Results are accompanied by a statistical 
analysis, established by software, which determines areas under curve obtained by a sequencer. 
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include sets of specific primers for different targets. In this PCR is important the design of 
primers because they must be characterized by adherence to specific DNA sequences at 
similar temperatures. However, it may require several trials to achieve the standardization 
of the procedure [8, 9]. 
 
Fig. 4. Electrophoretogram which shows deletions associated with Duchenne Muscular 
Dystrophy (DMD). In this figure is noted the absence of peaks in men with deletions.  
Area under the curve in women with DMD is reduced compared to normal control  
[13, 14].  
1.3 Nested PCR 
This PCR increases the sensitivity due to small amounts of the target are detected by using 
two sets of primers, involving a double process of amplification [15, 16]. The first set of 
primers allows a first amplification. The product of this PCR is subjected to a second PCR 
using the second set of primers. These primers used in the second PCR are specific to an 
internal amplified sequence in the first PCR. Therefore, specificity of the first PCR product is 
verified with the second one. The disadvantage of this technique is the probability of 
contamination during transfer from the first amplified product into the tube in which the 
second amplification will be performed. Contamination can be controlled using primers 
designed to anneal at different temperatures. Contamination can also be controlled by 
adding ultra-pure oil to make a physical separation of two mixtures of amplification  
[15, 17, 18]. 
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1.4 Reverse Transcriptase PCR (RT-PCR) 
This PCR was designed to amplify RNA sequences (especially mRNA) through synthesis of 
cDNA by reverse transcriptase (RT). Subsequently, this cDNA is amplified using PCR. This 
type of PCR has been useful for diagnosis of RNA viruses, as well as for evaluation of 
antimicrobial therapy [18, 19, 20, 21]. It has also been used to study gene expression in vitro, 
due to the obtained cDNA retains the original RNA sequence. The main challenge of using 
this technique is the sample of mRNA, because this is considered difficult to handle by low 
level and concentration of mRNA of interest and low stability at room temperature together 
with sensitivity to action of ribonucleases and pH change [20, 21, 22]. 
1.5 Semiquantitative PCR 
This technique allows an approximation to the relative amount of nucleic acids present in a 
sample, as mentioned above. cDNA is obtained by RT-PCR when sample is RNA. Then, 
internal controls (that are used as markers) are amplified. The markers commonly used are 
Apo A1 and B actin. Amplification product is separated by electrophoresis. Agarose gel is 
photographed after ethidium bromide staining, and optical density is calculated by a 
densitometer. The disadvantage of the technique is possibility of nonspecific hybridizations, 
generating unsatisfactory results. Control of specificity is performed using highly specific 
probes for hybridization [23, 24] (figure 5). 
1.6 Real time PCR 
Real time PCR or quantitative PCR (qPCR) is other adaptation of the PCR method to 
quantify the number of copies of nucleic acids during PCR. Thus, qPCR is used to quantify 
DNA o cDNA, determining gene or transcript numbers present within different samples [25, 
26, 27]. qPCR offers advantages such as speed in the result, the reduced risk of 
contamination and the ease in handling technology [28, 29]. This PCR uses fluorescence 
detection systems which are generally of two types: intercalating agents and labeled probes 
with fluorophores.  
Intercalating agents such as SYBR Green are fluorochromes that dramatically increase the 
fluorescence by binding to a double-stranded DNA [30, 31, 32]. Thus, the increase of DNA in 
each cycle reflects a proportional increase in the emitted fluorescence. However, it is 
considered that intercalating agents offer a low specificity because they can be bind to 
nonspecific products or primer dimers. Several studies have shown that careful selection of 
primers and using of optimal PCR conditions may minimize this nonspecificity [28, 32, 33]. 
The use of a high temperature to start the synthesis reaction (hot-start PCR) decreases the 
risk of nonspecific amplification. Another detection system used in real time PCR are 
specific hybridization probes labeled with two types of fluorochromes, a donor and an 
acceptor. The most commonly used probes are hydrolysis or TaqMan probes, molecular 
beacons probes, and FRET (fluorescent resonance energy transfer) [32, 33, 34]. The increase 
of DNA in each cycle is proportional to hybridization of probes, which in turn is 
proportional to the increase in the emitted fluorescence. The use of probes allows 
identifying polymorphisms and mutations; however, these are more complex and expensive 
than intercalating agents [35, 36, 37]. 
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Fig. 5. Semiquantitative PCR procedure. This technique is useful for identifying small 
amounts of nucleic acids. 
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2. Applications of PCR and impact on science 
During the past 30 years molecular techniques have been under development, however 
these have had a rapid and tremendous progress in recent year [38]. Among molecular 
techniques, PCR and its different variations are highlighted as the most commonly used in 
laboratories and research institutes. Thus, these have contributed to identification and 
characterization of several organisms and understanding of physiopathology of diverse 
diseases in human, animal and plant [39, 40]. Also these have provided clues for future 
research directions in specific topics with impact in public health such as genetics and 
biochemistry of antimicrobial resistance [41, 42]. The following describes some applications 
of PCR and its variants in studies in human medicine, forensic sciences, and agricultural 
science and environment. 
2.1 Medicine 
Molecular biology techniques, particularly PCR, have had a major impact on medicine. The 
versatility of molecular techniques has allowed advances and changes in all fields of 
medicine. The following is an overview of the main impacts generated for molecular biology 
in medical sciences. 
Clinical microbiology has been transformed with the use of molecular technology because it 
has generated a benefit to the patient affected by infectious diseases. Molecular biology has 
allowed the development of clinical microbiology because it has been possible to identify 
microorganisms that are difficult to culture, that have many requirements of laboratory or 
dangerous for laboratory personnel. These problems have been reduced with the 
implementation of molecular diagnosis that provides high sensitivity, specificity, precision 
and speed with one small sample. These applications are transforming and complementing 
the work of biochemists, immunologists, microbiologists and other health professionals who 
see in the molecular tools new alternatives for a rapid diagnosis of microorganisms as well 
as for the determination of multiple factors associated with antibiotic resistance thus 
expanding the knowledge of microbial epidemiology and surveillance at the genetic level 
[43, 44, 45]. 
The usefulness of PCR in identification of microorganisms has led to the selection and 
quality assurance of blood that blood banks are using for patients with different pathologies 
[46]. The incorporation of molecular techniques has been of great importance in the 
identification and characterization of many viruses, including influenza, which through a 
rapid, sensitive, and effective molecular diagnosis has allowed inclusion of early treatment 
to benefit patients and control of a high impact infection [47, 48].  
The implementation of molecular tools has allowed a transformation of pathological studies 
and has changed the clinical practice. This is how the diagnosis and treatment of complex 
diseases that require a multidisciplinary clinical team currently has a base of molecular 
biology due to histopathological evaluation of tissues, which is an important part in the 
morphological assessment, is insufficient by itself. Thus, the ability to define molecular 
alterations associated with the disease is increasingly required to clarify the diagnosis and 
therapeutic guidance [48]. At pathological level, molecular biology has allowed the 
identification of mutations and carriers of diseases as in diabetes, obesity, neurological, 
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muscular, cardiac, metabolic, and congenital diseases and pathologies associated with 
sensory organs. At the ocular level, implementation of molecular biology has generated 
enormous advances in knowledge, diagnosis and treatment of ophthalmic diseases [49, 50]. 
The usefulness of this technique in the identification of mutations associated with ocular 
diseases has been widely used for the study of families at risk. Several reports show how 
PCR has allowed expanding the knowledge of certain diseases; thus, Woloschak et al. 1994 
[51] showed the loss of heterozygosity in the retinoblastoma gene in pituitary human 
tumors. It was possible to demonstrate genetic heterogeneity in congenital fibrosis of 
extraocular muscles. With the advent of molecular technology, it has been possible to 
understand certain aspects of diseases as in retinitis pigmentosa, microftalmia, 
retinoblastoma, open-angle glaucoma, ocular diseases due to alterations in mitochondrial 
DNA and various types of corneal dystrophy, among others [50, 52, 53]. Also, genes that 
cause ocular diseases have been cloned at the anterior and posterior segment. In anterior 
segment basically aniridia and Peter’s anomaly, autosomal dominant diseases in which have 
been identified candidate genes [54]. In posterior segment, the number of cloned genes has 
been higher; these are associated with different pathologies described as following. Retinitis 
pigmentosa with autosomal dominant inheritance pattern in most cases; however, it can also 
be found in a recessive or digenic form [55]. Congenital Stationary Night Blindness, a 
disease whose pattern of inheritance is autosomal dominant. Retinoblastoma which the 
genetic defect affects the retinoblastoma protein (Rb) whose gene rb has been cloned [56]. 
Cones degeneration inherited pattern linked to X, this means that the disease is transmitted 
by a carrier mother, where 50% of boys are likely to get the disease and 50% of their 
daughters are likely to pass it. Its alteration affects synthesis of red opsin [57, 58]. Leber 
hereditary optic neuropathy associated with alteration of mitochondrial DNA whose defect 
involves activity of mitochondrial enzymes [57]. These findings have strong implications for 
the understanding of physiopathology of these genetic entities and generate a new concept 
of ocular clinical practice due to advances in molecular biology not only can classify better 
the pathology but the diagnosis becomes specific and safe. On the other hand, in those 
ocular diseases attributed to mutations in genes located on chromosome X, it is possible to 
identify mothers or women on the mother line and to generate secondary prevention 
measures when inform the carrier or not carrier status of them [49]. 
Molecular tools have also allowed to perform preimplantation genetic diagnosis (PGD) 
being used for genetic analysis of embryos before transfer into the uterus. It was first 
developed in England in 1990, as part of the advances in reproductive medicine, genetics 
and molecular biology. PGD offers couples at risk of having an affected child the 
opportunity to have normal child by assisted fertilization. The molecular genetic analysis is 
performed on one or two blastomeres, and only unaffected embryos are transferred into the 
uterus. It is important to note that in many countries the using of this reproductive 
procedure has caused controversy. However, this technique provides an opportunity for 
couples whose children have shown earlier genetic abnormalities [59, 60, 61]. 
2.2 Forensic science 
In forensic pathology, classic morphology remains as a basic procedure to investigate 
deaths, but recent advances in molecular biology have provided a very useful tool to 
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research systemic changes involved in the pathophysiological process of death that cannot 
be detected by morphology. In addition, genetic basis of diseases with sudden death can 
also be investigated with molecular methods. Practical application of RNA analysis has not 
been accepted for post-mortem research, due to rapid decomposition after death. However, 
recent studies using variants of conventional PCR (qPCR and RT-PCR) have suggested that 
relative quantification of RNA transcripts can be applied in molecular pathology to research 
deaths ("molecular autopsy"). In a broad sense, forensic molecular pathology involves 
application of molecular biology in medical science to investigate the genetic basis of 
pathophysiology of diseases that lead to death. Therefore, molecular tools support and 
reinforce the morphological and physiological evidence in research of unexplained death 
[62]. 
Molecular methods are used in forensic science to establish the filiations of a person 
(paternity testing) or to obtain evidence from minimal samples of saliva, semen or other 
tissue debris [63]. Genetic profile of the alleles identified in different regions of DNA is 
performed in paternity tests using a genetic marker STR (Short Tandem Repeat). Each 
region has an allele contributed by mother and one from father. This profile is virtually 
unique to each individual, offering a high power molecular evidence of genetic 
discrimination [64, 65]. 
2.3 Agricultural sciences and environment 
Applications of molecular techniques in research in agricultural sciences and environment 
have been very numerous and varied. It is possible that one of the most important 
contributions of the applications of some molecular techniques such as PCR has been the 
identification and characterization of multiple infectious agents that have great impact on 
human and animal health. Some applications in agricultural science and environment 
research are described below. 
Currently, the genome of most domestic animals and major infectious agents that affect 
animals is known through the use of molecular tools, facilitating the study of mutations 
associated with disease (http://www.ncbi.nlm.nih.gov/genomes/leuks.cgi). Some of the 
most recent reports are listed below: i. the identification of polymorphisms in ABCB1 
gene in phenobarbital responsive and resistant idiopathic epileptic Border Collies [66]; ii. 
A mutation of EDA gene associated with anhidrotic ectodermal dysplasia in Holstein 
cattle [67]; iii. The deletion of Meq gene which significantly decreases 
immunosuppression in chickens caused by Marek's disease virus [68]; iv. The MTM1 
mutation associated with X-linked myotubular myopathy in Labrador Retrievers [69]; v. 
An insertion mutation in ABCB4 associated with gallbladder mucocele formation in dogs 
[70]; among others. 
Molecular techniques such as conventional PCR or qPCR have also facilitated research in 
detection of pathogens in plants, animals, and the environment; understanding of their 
epidemiology; and, development of new diagnostic tests, treatments or vaccines. 
Conventional PCR or PCR based methods are being applied to identification and 
characterization of specific pathogens of animals, e.g., infectious bursal disease virus in 
avian samples [71]; bovine respiratory syncytial virus [72]; Actinobacillus pleuropneumoniae 
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from samples of pigs [73]; canine parvovirus type 2 (CPV 2) in faecal samples of dogs [74]; 
feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) [75]; among others. 
Nucleic acid based detection methods are also important to identification of foodborne 
pathogens, such as Listeria monocytogenes [76]; Campylobacter spp., Salmonella enterica, and 
Escherichia coli O157:H7 [77].  
Despite these important applications of molecular methods, one of the purposes with the 
greatest impact is the detection and characterization of agents with zoonotic potential, such 
as pandemic (H1N1) influenza [78]; leptospirosis [39]; Canine visceral leishmaniasis [79]; 
among others.  
In summary, PCR has advantages as a diagnostic tool in conventional microbiology, 
particularly in the detection of slow growing or difficult to cultivate microorganisms, or 
under special situations in which conventional methods are expensive or hazardous. Due to 
the stability of DNA, nucleic acid based detection methods can be also used when inhibitory 
substances, such as antimicrobials or formalin, are present [80]. Therefore, through the use 
of molecular techniques has been able to identify different pathogens, to elucidate its 
epidemiology, to achieve standardization of diagnostic methods, and to establish strategies 
of prevention and control of diseases, advancing in sanitary regulations in different 
countries. 
3. Conclusions 
New knowledge has been generated in different fields of science with invention of PCR 25 
years ago. The applications of molecular biology have transformed diagnosis, prognosis and 
treatment of many diseases. Likewise, molecular methodologies to measure and evaluate 
gene expression have become the key techniques of the post-genomic era. This correlates 
with the increasing number of reports of molecular technologies to identify and characterize 
multiple infectious agents and diseases affecting humans, plants, and animals. The above 
mentioned justifies the establishment of clear regulations and statistical models for 
evaluation and adoption of these protocols in laboratories of diagnosis [81]. Despite the 
continuing evolution of molecular biology, future efforts should continue to increase 
understanding of advantages and disadvantages of molecular methods in diagnosis, and its 
interpretation within the clinical context. In addition, it is necessary to increase research for 
the development of guideline for standardization, validation and comparison new 
molecular diagnostic methods with existing techniques regarding to sample type, sample 
preparation, PCR amplification, and reporting of results [80]. In conclusion, the 
development of molecular biology techniques such as PCR and its variants has led to 
advances in medicine, agriculture, animal science, forensic science and environment, among 
others; transforming the society and economy, and influencing the quality of life of people 
and the development of science and countries. 
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